Dr. Lawrence Feldman is an Associate Professor of Hematology and Oncology. His research interests are in the areas of early detection, treatment, and supportive care of lung cancer. Dr. Feldman’s clinical research in the treatment of lung cancer is currently focused on immunotherapy of lung cancer, in particular the use of immune checkpoint inhibitors in combination with agents that may act synergistically to improve their effectiveness against patients’ tumors.
His research is focused on lung, head and neck cancer. He also researches about early detection and immunotherapy.